Rope Pharma Private Limited
About Rope Pharma Private Limited
Data last updated:
Rope Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2021PTC382553.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Kumar and Pramod Sethi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 294 Plot 2A First Floor Kehar Singh Estate Saidulajab, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.68 Cr. For the same year it recorded a net loss of ₹4.83 Lakh (net margin -0.6%) and EBITDA of -₹6.46 Lakh (EBITDA margin -0.8%).
Company details
Contact details
Rope Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 294 Plot 2A First Floor Kehar Singh Estate Saidulajab, Delhi, India – 110030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rope Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rope Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Rope Pharma Private Limited, buy the company report.
Financials of Rope Pharma Private Limited
FY 2025 filings availableRope Pharma Private Limited reported revenue of ₹7.68 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹6.46 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹4.83 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.8% | |||
| Net Profit Margin | -0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rope Pharma Private Limited, buy the company report.
Board of directors of Rope Pharma Private Limited
Rope Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Also directs: Manpra Pharm Private Limited, Save Earth Labs Private Limited, God Gift Laboratory Private Limited and 2 more | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
| Pramod Sethi Also directs: Manpra Pharm Private Limited, Save Earth Labs Private Limited, God Gift Laboratory Private Limited and 2 more | Director | 22 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Rope Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tantra-Chem India Private Limited | ₹7.88 Cr (FY 2025) | 45.0% | Lote, Maharashtra, India | |||
| Trans Lifescience Medcare Private Limited | ₹7.8 Cr (FY 2024) | 29.0% | Sonipat, Haryana, India | |||
| Indionix Medical Device Private Limited | ₹7.79 Cr (FY 2025) | 345.0% | Lucknow, Uttar Pradesh, India | |||
| Clavita Pharma Private Limited | ₹7.76 Cr (FY 2025) | -31.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Chandravardhan Organics Pvt Ltd | ₹7.75 Cr (FY 2025) | 11.0% | Solapur, Maharashtra, India | |||
| Rope Pharma Private Limitedthis company | ₹7.68 Cr (FY 2025) | -₹4.83 Lakh | -0.6% | Delhi, India | ||
| Elegance Life Sciences Private Limited | ₹7.61 Cr (FY 2025) | 46.0% | Noida, Uttar Pradesh, India | |||
| Santec Chemical Private Limited | ₹7.59 Cr (FY 2025) | 69.0% | Ernad, Kerala, India | |||
| Kamal Pharmacy (Ayurvedic) Private Limited. | ₹7.57 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Girgan Fine Chem Private Limited | ₹7.51 Cr (FY 2025) | -22.0% | Alwar, Rajasthan, India | |||
| Shiv Pharma Private Limited | ₹7.5 Cr (FY 2025) | 0.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Rope Pharma Private Limited, buy the company report.
Auditor
Rope Pharma Private Limited is audited by MANOJKUMARPAHWA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJKUMARPAHWA | FY 2023 | 099283 |
Shareholding
The shareholding of Rope Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rope Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rope Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rope Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rope Pharma Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
No GST registration is on our record for Rope Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rope Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manish Kumar was appointed as Director on 22 Jun 2021.
Frequently asked questions
Rope Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 June 2021 (5+ years old) and is registered under CIN U24230DL2021PTC382553.
Rope Pharma has 2 current directors:
- Manish Kumar - Director
- Pramod Sethi - Director
The latest financial statements of Rope Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Rope Pharma is U24230DL2021PTC382553. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rope Pharma was incorporated on 22 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rope Pharma by revenue are Tantra-Chem India Private Limited, Trans Lifescience Medcare Private Limited, Indionix Medical Device Private Limited, Clavita Pharma Private Limited, Chandravardhan Organics Pvt Ltd and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Manish Kumar was appointed as Director on 22 Jun 2021. Pramod Sethi was appointed as Director on 22 Jun 2021.
The registered office of Rope Pharma is at H – 294 Plot 2A First Floor Kehar Singh Estate Saidulajab, Delhi, India – 110030.
Rope Pharma operates in the pharma industry, in the drug formulation and development segment.
Rope Pharma can be reached at its registered office: H – 294 Plot 2A First Floor Kehar Singh Estate Saidulajab, Delhi, India – 110030.
Rope Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
